Queensland Facility for Advanced Genome Editing (QFAGE)

People with higher genetic risk of clinical depression are more likely to have physical symptoms such as chronic pain, fatigue and migraine.

A research paper published in Nature journal overnight revealed that scientists had successfully edited the genomes of human embryos to prevent a mutation that causes hypertrophic cardiomyopathy, an inherited condition that causes sudden heart failure in young people.

Professor Peter Koopman speaks about his research into CRISPR and the possibilities it could offer to future generations, as well as those suffering from genetic conditions right now.

IMB recently launched its new Queensland Facility for Advanced Genome Editing (QFAGE), based at UQ's St Lucia campus, which provides expert genetic modification services using CRISPR/Cas9 genome editing technology in mice.